Skip navigation
Oslo Economics logo
About us
News
Our services
Subject areas
Research

Impact analysis of the multinational pharmaceutical industry

12.05.2016 - Health and life science

A new report by Oslo Economics and BI Norwegian Business School analyzes the impacts of the multinational pharmaceutical industry on Norway’s economy and society. The study was carried out on behalf of the American Chamber of Commerce in Norway

The aim of the report is to highlight the main ways in which the industry contributes to the Norwegian economy and society and provide comparisons with other sectors in Norway and with similar sectors in other countries. The analysis is based on official accounting data, information from in-depth interviews and data from an online questionnaire conducted in 2015.

Read the full report in English or Norwegian at AmChams website.

Relevant articles

Analysis of the marginal costs of activity growth in the Norwegian specialist health service

Oslo Economics, in collaboration with Sverre Kittelsen (Frisch Centre), Kjartan Sarheim Anthun (SINTEF) and Jon Magnussen (NTNU), has calculated the marginal costs associated with increasing the activity levels in the Norwegian specialist health service. The study is part of the foundation for the Norwegian government’s recently announced healthcare plan and has been conducted on the behalf of the Ministry of Health and Care Services.

The proposal from the Abortion Committee will provide an increased degree of reproductive freedom for women.

On behalf of the Abortion Committee, Oslo Economics has assessed the economic consequences of the committee’s proposed changes to the abortion law, as well as other measures related to improved information, increased competence in healthcare services, and more knowledge about abortion in Norway.

Does primary health care teams contribute to better health care services for patients at the general practitioner offices?

Since April 2018, a total of 17 general practitioner (GP) offices have participated in a pilot project with primary health care teams (PHT) and two alternative financing schemes. Results from the pilot study indicate that GP offices experience that PHT offer new solutions to their challenges, and further that most patients were satisfied with the follow-up and would like to continue with nurse consultations

Bergen

Markeveien 1, 5012 Bergen
post.bergen@osloeconomics.no

Oslo

Klingenberggata 7A, 0161 Oslo
post@osloeconomics.no
Tel: +47 21 99 28 00
(Hovedkontor)

Berlin

Krausenstraße 9, 10117 Berlin
post@osloeconomics.de

GDPR Aktsomhetsvurderinger Utviklet av Normand Technologies AS